Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:03 PM
Ignite Modification Date:
2025-12-24 @ 5:03 PM
NCT ID:
NCT00754650
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients, ≥ 18 years of age.
* B-chronic lymphocytic leukemia not yet requiring treatment.
* Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
* No previous treatment of chronic lymphocytic leukemia (CLL) by chemotherapy, radiotherapy, or immunotherapy.
* Life expectancy \> 6 months.
Exclusion Criteria:
* Central nervous system (CNS) involvement by lymphoma or any evidence of spinal cord compression.
* Computed tomography (CT) scan based evidence of tumor invading major blood vessels.
* Gastrointestinal (GI) tract involvement by CLL.
* Active viral, bacterial, or fungal infection.
* Uncontrolled hypertension, cerebrovascular accident/stroke (≤ 6 months prior to randomization), myocardial infarction (≤ 6 months prior to randomization), unstable angina (≥ New York Heart Association (NYHA) Grade IV), thrombosis within 6 months before enrollment, NYHA Grade II congestive heart failure, or serious cardiac arrhythmia requiring ongoing medication.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00754650
Study Brief:
Protocol Section:
NCT00754650